The study drug is a potential new treatment for heart failure.
Heart failure, also known as congestive heart failure is a condition that occurs when the heart does not pump enough blood that the body requires. More than half of all people with congestive heart failure have a survival rate of 5 years after diagnosis.
This healthy volunteer study hopes to explore medication administration promoting anti-inflammatory effects, beneficial for people with heart failure.
The trial has been approved by an independent ethics committee and eligible participants will be reimbursed for their time.
Call us on 1800 243 733 to discuss your eligibility today!